The Ages and Stages Questionnaires–3® (ASQ-3) for developmental screening in our young oncology patients was pilot tested in children 4 to 48 months of age with newly diagnosed cancer. Subjects were screened within 28 days of diagnosis (baseline), at 6 and 12 months. Twenty-six of 30 enrolled parents (87%) completed all 3 screens. Screens were completed by parents within 15 minutes. ASQ-3 screening identified unsuspected developmental delays as follows: 7 at baseline, 4 at 6 months, and 3 at 12 months. ASQ-3 developmental screening is feasible, identifies early developmental delays in young children with cancer, and helps initiate appropriate referrals.
American Academy of Pediatrics, Committee on Children With Disabilities. (2001). Developmental surveillance and screening of infants and young children. Pediatrics, 108, 192-196.
2.
American Academy of Pediatrics Section on Hematology/Oncology Children’s Oncology Group. (2009). Long-term follow-up care for pediatric cancer survivors. Pediatrics, 123, 906-915.
3.
BhatiaS.ConstineL. S. (2009). Late morbidity after successful treatment of children with cancer. Cancer Journal, 15, 174-180.
4.
BornsteinM. H.ScriminS.PutnickD. L.CapelloF.HaynesO. M.de FalcoS.PillonM. (2012). Neurodevelopmental functioning in very young children undergoing treatment for non-CNS cancers. Journal of Pediatric Psychology, 37, 660-673.
5.
Council on Children With Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children With Special Needs Project Advisory Committee. (2006). Identifying infants and young children with developmental disorders in the medical home: An algorithm for developmental surveillance and screening. Pediatrics, 118, 405-420.
6.
EmbryL.AnnettR. D.Kunin-BatsonA.PatelS. K.SandsS.ReamanG.NollR. B. (2012). Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: Can it be done?Pediatric Blood & Cancer, 59, 536-539.
7.
FriedmanD. L.FreyerD. R.LevittG. A. (2006). Models of care for survivors of childhood cancer. Pediatric Blood & Cancer, 46, 159-168.
8.
GlascoeF. P. (1997). Parents’ concerns about children’s development: Prescreening technique or screening test?Pediatrics, 99, 522-528.
9.
HookeM. C.GarwickA. W.GrossC. R. (2011). Fatigue and physical performance in children and adolescents receiving chemotherapy. Oncology Nursing Forum, 38, 649-657.
10.
JanzenL. A.SpieglerB. J. (2008). Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment. Developmental Disabilities Research Reviews, 14, 185-195.
11.
KrullK. R.OkcuM. F.PotterB.JainN.DreyerZ.KamdarK.BrouwersP. (2008). Screening for neurocognitive impairment in pediatric cancer long-term survivors. Journal of Clinical Oncology, 26, 4138-4143.
12.
LancashireE. R.FrobisherC.ReulenR. C.WinterD. L.GlaserA.HawkinsM. M. (2010). Educational attainment among adult survivors of childhood cancer in Great Britain: A population-based cohort study. Journal of the National Cancer Institute, 102, 254-270.
13.
LeungW.HudsonM. M.StricklandD. K.PhippsS.SrivastavaD. K.RibeiroR. C.PuiC. H. (2000). Late effects of treatment in survivors of childhood acute myeloid leukemia. Journal of Clinical Oncology, 18, 3273-3279.
14.
LopezV.CliffordT.MinnesP.Ouellette-KuntzH. (2008). Parental stress and coping in families of children with and without developmental delays. Journal on Developmental Disabilities, 14, 99-104.
15.
MilesM. S. (2003). Parents of children with chronic health problems: Programs of nursing research and their relationship to developmental science. Annual Review of Nursing Research, 21, 247-277.
16.
MilesM. S.Holditch-DavisD. (2003). Enhancing nursing research with children and families using a developmental science perspective. Annual Review of Nursing Research, 21, 1-20.
17.
NathanP. C.PatelS. K.DilleyK.GoldsbyR.HarveyJ.JacobsenC.ArmstrongF. D. (2007). Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: A report from the Children’s Oncology Group. Archives of Pediatrics & Adolescent Medicine, 161, 798-806.
18.
PejnovicL. P.De LucaC. R.GentleE.AnsonK.AshleyD. M.AndersonV. A.McCarthyM. C. (2012). Feasibility of neurobehavioral screening following diagnosis of pediatric cancer. Pediatric Blood & Cancer, 59, 295-300.
19.
ReddyA. T.WitekK. (2003). Neurologic complications of chemotherapy for children with cancer. Current Neurology & Neuroscience Reports, 3, 137-142.
20.
RodriguezE. M.DunnM. J.ZuckermanT.VannattaK.GerhardtC. A.CompasB. E. (2012). Cancer-related sources of stress for children with cancer and their parents. Journal of Pediatric Psychology, 37, 185-197.
21.
RosenbergS. A.ZhangD.RobinsonC. C. (2008). Prevalence of developmental delays and participation in early intervention services for young children. Pediatrics, 121, e1503-e1509.
22.
SquiresJ.BrickerD.PotterL. (1997). Revision of a parent-completed development screening tool: Ages and Stages Questionnaires. Journal of Pediatric Psychology, 22, 313-328.
23.
SquiresJ.BrickerD. D.TwomblyE. (2009). Ages & stages questionnaires: A parent-completed child monitoring system (3rd ed.). Baltimore, MD: Paul H. Brooks.
